Search results
Sex-dependent interactions between prodromal intestinal inflammation and LRRK2 G2019S in mice...
Nature· 1 day agoProdromal gut inflammation exacerbates Parkinson’s disease endophenotypes in mouse carriers of human LRRK2 G2019S in a sex-dependent ...
Study identifies genetic link between inflammatory bowel disease and Parkinson's disease
Medical Xpress· 2 days agoResearchers at the Icahn School of Medicine at Mount Sinai have made a significant discovery, identifying genetic connections between inflammatory bowel disease (IBD) and ...
DWP responds after demanding woman, 93, with dementia repays £7,000
Daily Express· 7 hours agoIts remorse came after the elderly lady failed to disclose a change in her circumstances five years...
Experimental spinal cord implant helps Parkinson’s patient walk in new study
CNN via Yahoo News· 7 days agoMarc Gauthier can now step into an elevator without his body stiffening and freezing in place. He...
New biomarker identified to diagnose Alzheimer's in asymptomatic stages
Medical Xpress· 22 hours agoMolecular Basis of Disease. The search for biomarkers that are stable and easily detectable in...
UAB identifies a protein that could change the battle against Parkinson's disease
Hardwood Paroxysm· 5 days agoResearchers at the Autonomous University of Barcelona have found a therapeutic target to neutralize...
Neuralink Rival Backed By Jeff Bezos And Bill Gates Broadens Horizons With Plans To Treat Parkinson'...
Benzinga· 6 days agoWhat Happened: On Thursday at the Bloomberg Tech Summit, Synchron’s founder, Tom Oxley, disclosed...
Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic...
WFRV 5 Green Bay· 2 hours agoIonis Pharmaceuticals, Inc. (Nasdaq: IONS) and Biogen Inc. (Nasdaq: BIIB) announced the decision to terminate development of BIIB105 (ION541) an investigational antisense oligonucleotide (ASO ...
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International...
Benzinga· 2 hours agoNKGN ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic...Executive Officer ...
Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate...
Morningstar· 7 days agoPhase 2a trials of CNS-Penetrant NLRP3 Inhibitor VTX3232 to initiate in H2 2024 in patients with early Parkinson’s disease and in participants ...